ADP Receptors and Clinical Bleeding Disorders
- 1 October 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (10) , 2281-2285
- https://doi.org/10.1161/01.atv.19.10.2281
Abstract
—ADP plays a key role in hemostasis and thrombosis. Despite its early identification in 1961 as the first known aggregating agent, the molecular basis of ADP-induced platelet activation is ...Keywords
This publication has 31 references indexed in Scilit:
- Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptorsEuropean Journal of Pharmacology, 1998
- Effect of clopidogrel treatment on ADP‐induced phosphorylations in rat plateletsBritish Journal of Haematology, 1997
- The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cellsPublished by Wiley ,1997
- P2 purine and pyrimidine receptors: emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptorsEuropean Journal of Medicinal Chemistry, 1997
- Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptorsBritish Journal of Haematology, 1995
- A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosisTrends in Pharmacological Sciences, 1995
- An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.Journal of Clinical Investigation, 1995
- Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADPBritish Journal of Haematology, 1994
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993
- The Basic Pharmacology of Ticlopidine and ClopidogrelPlatelets, 1993